Powered by GoogleTranslate

Inspection Detail

Inspection: 307104430 - Ivax Pharmaceutical Caribe Inc

Inspection Information - Office: Pr-E-Caguas 0257220

 

Inspection Nr: 307104430
Report ID: 0257220
Date Opened: 12/22/2003

Site Address:
Ivax Pharmaceutical Caribe Inc
Cidra Industrial Park Carr 171 Km 0.5
Cidra, PR 00739

Mailing Address:
Po Box 11979, Cidra, PR 00739

Union Status: NonUnion

SIC:2834

NAICS: 325412/Pharmaceutical Preparation Manufacturing


Inspection Type: Complaint

Scope: Partial

Advanced Notice: N

Ownership: Private

Safety/Health: Health

Close Conference: 07/12/2004

Emphasis:

Case Closed: 04/21/2005


Related Activity
Type Activity Nr Safety Health
Complaint 201709078 Yes
Violation Summary
Violations/Penalties Serious Willful Repeat Other Unclass Total
Initial Violations 5 5
Current Violations 5 5
Initial Penalty $0 $0 $0 $8,250 $0 $8,250
Current Penalty $0 $0 $0 $4,125 $0 $4,125
FTA Penalty $0 $0 $0 $0 $0 $0

Violation Items
# Citation ID Citaton Type Standard Cited Issuance Date Abatement Due Date Current Penalty Initial Penalty FTA Penalty Contest Latest Event Note
1. 01001 Other 19100134 D01 I 08/18/2004 05/20/2004 $1,313 $2,625 $0 09/14/2004 J - ALJ Decision  
2. 01002 Other 19100134 E01 08/18/2004 08/23/2004 $750 $1,500 $0 09/14/2004 J - ALJ Decision  
3. 01003 Other 19100134 F02 08/18/2004 08/23/2004 $1,313 $2,625 $0 09/14/2004 J - ALJ Decision  
4. 01004 Other 19100134 G01 III 08/18/2004 08/23/2004 $750 $1,500 $0 09/14/2004 J - ALJ Decision  
5. 02001 Other 19101200 G08 08/18/2004 08/23/2004 $0 $0 $0 09/14/2004 J - ALJ Decision  
Back to Top

Thank You for Visiting Our Website

You are exiting the Department of Labor's Web server.

The Department of Labor does not endorse, takes no responsibility for, and exercises no control over the linked organization or its views, or contents, nor does it vouch for the accuracy or accessibility of the information contained on the destination server. The Department of Labor also cannot authorize the use of copyrighted materials contained in linked Web sites. Users must request such authorization from the sponsor of the linked Web site. Thank you for visiting our site. Please click the button below to continue.

Close